Total declarations
Company
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Latest filing published 28 Mar 2017 for BioPharma Credit PLC, €92k.
Filing timeline
BuySaleHarry Hyman
Insider track record
Disclosed buys
1
Disclosed sells
0
Signal history
No signal scores available.
Closed purchases
Market purchases
1
Not enough history yet: 1 closed purchase, at least 2 are needed.
Purchases by company
Since each purchase
- +0.1%Entry US$1.03 · Close at T+365 US$1.03
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Harry Hyman: trading record in brief
One trade, one date: on 28 March 2017, Harry Hyman disclosed an open-market purchase of €92k in BioPharma Credit PLC. No broader history exists yet. Source: insider filings from RNS (LSE). Past trades are no guide to future returns.
Companies and markets linked to Harry Hyman
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations1 total
- 100,000 shares@ US$1.00100.0% of flowLondon Stock Exchange (XLON)ISIN GB00BDGKMY29FCA-NSM:LSE20170328103001_13173891_20200330131526718_22287Canonical exit: 25 Jun 2017 (T+90)
1 of 1 declaration